Fable 5 Returns
US export controls on Fable 5 and Mythos 5 have lifted. Anthropic details the Amazon-reported bypass, its fix, and a new Glasswing-backed framework for scoring AI jailbreak severity
US export controls on Fable 5 and Mythos 5 have lifted. Anthropic details the Amazon-reported bypass, its fix, and a new Glasswing-backed framework for scoring AI jailbreak severity
Nearly half of everything you've watched on this channel in recent months has clustered around five conversations, and all five keep circling the same uncomfortable subject.
Nine month design cycle, deployment from end 2026, gigawatt scale rollout planned with Microsoft.
with granular admin controls, scoped API keys, multi-account support and a new debugging tool for MCP connections.
Agents plan, checklist and complete coding jobs unsupervised, with status, pause, resume and clear commands giving developers oversight throughout.
OpenAI's Daybreak shifts cyber AI focus from finding flaws to fixing them, pairing an upgraded GPT-5.5-Cyber and Codex Security with a new vendor partner programme and an open-source patching drive.
The road to hell is paved with good intentions, and most of them arrive as newsletters. On unsubscribe culture, marketing bullshit, and why your voice is more welcome here than your inbox space.
A government order pulls Fable 5 offline, OpenAI talks up its own safety testing, and Musk buys Cursor for $60bn. Plus: the ChatGPT story that makes the rest look small.
Jeff Bezos and Sundar Pichai are in the corner playing pool.
Pope Leo's encyclical on AI is one of the most serious documents written on the subject. The launch optics undermined it before most people read a word.
As Elon Musk testifies in Oakland, the lawsuit over OpenAI’s for-profit conversion establishes a high-stakes benchmark for AI governance and fiduciary duty.
The new partnership gives Cursor unprecedented compute access and gives SpaceX a path to dominate agentic software development.
While it promises rapid vulnerability detection, the emergence of Anthropic’s latest AI raises questions about security risks, defensive preparations, and the future of knowledge work.
Cycode’s Top AI Security Vulnerabilities to Watch out for in 2026 report outlines rising risks across prompt injection, data exposure, and AI supply chains.
Security models are no longer enough as multi-modal attacks overwhelm traditional controls, forcing a rethink of enterprise trust systems.
MCP is rapidly transforming how AI agents interact with enterprise systems, opening up a new class of supply chain, identity, and governance risks that security teams can’t ignore.
Hefty cash burn threatens OpenAI’s longevity in the face of self-funded competitor.
Google DeepMind CEO warns that defensive systems must outpace AI-powered attack vectors as AGI approaches.
From the EU AI Act to cyber policy wording, panelists examined how emerging regulation and insurance structures intersect with enterprise AI deployment.
Supreme Court allows appeal in Emotional Perception AI v. Comptroller General, mandating EPO-aligned test for computer-implemented inventions under UK law.
Experts discuss the practical steps organizations must take to secure AI, protect data, and operationalize responsible deployments.
OpenAI partners with Sanofi, Simplon, Mirakl & ESCP in France, focusing on clinical trials, education, marketplace growth & personalised learning.
NVIDIA leads 750+ open-source projects, contributing to CNCF initiatives over a decade to democratise AI development tools and cloud tech.
GluFormer uses GPT-style transformer architecture to predict glucose from 15-minute readings, foreseeing responses to specific foods and tracking multiple health metrics.
New prompt improver uses chain-of-thought, XML standardisation, and prefill features to enhance prompts, boosting accuracy by 30% in classification tests.
Company ranked first among 2,000 evaluated firms, excelling in employee benefits with quarterly Free Days and onsite counsellors, while maintaining low turnover
Company created 240 custom GPTs in 10 weeks, including specialised tools for fragrance analysis and clinical trials, achieving 90% faster response times.